CASI Pharmaceuticals Inc. (CASI)

AI Score

Unlock

2.13

0.02 (0.95%)

At close: Apr 03, 2025, 3:58 PM

2.20

3.53%

After-hours: Apr 03, 2025, 06:14 PM EDT

CASI Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994	FY 1993	FY 1992	FY 1991
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002	Dec 31, 2001	Dec 31, 2000	Dec 31, 1999	Dec 31, 1998	Dec 31, 1997	Dec 31, 1996	Dec 31, 1995	Dec 31, 1994	Dec 31, 1993	Dec 31, 1992	Dec 31, 1991
Revenue	33.88M	43.11M	30.17M	15.14M	4.13M	n/a	n/a	n/a	47.71K	23.73K	n/a	669.31K	1.94M	3.69M	5.28M	7.48M	7.4M	6.89M	5.92M	514K	1.58M	1.18M	1.86M	3.67M	5M	5.2M	4.8M	4.4M	720K	90K	n/a	n/a	n/a
Cost of Revenue	13.83M	15.83M	12.56M	9.51M	3.94M	1.67M	117.78K	66.45K	6.27K	7.47K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.08M	-900K	-700K	-300K	7.4M	n/a	n/a	n/a	n/a	n/a
Gross Profit	20.05M	27.28M	17.61M	5.63M	196K	-1.67M	-117.78K	-66.45K	41.44K	16.26K	n/a	669.31K	1.94M	3.69M	5.28M	7.48M	7.4M	6.89M	5.92M	514K	1.58M	1.18M	1.86M	4.75M	5.9M	5.9M	5.1M	-3M	720K	90K	n/a	n/a	n/a
Operating Income	-25.08M	-26.49M	-35.28M	-33.31M	-39.99M	-26.5M	-10.75M	9.42M	7.15M	26.19M	5.74M	4.5M	-4.57M	-4.53M	6.72M	22.36M	23.73M	51.65M	17.33M	16.58M	19.7M	44.06M	66.81M	50.72M	-38.5M	15.7M	-9.1M	6.6M	-7.69M	-5.13M	-6.33M	-1.46M	-20K
Interest Income	614K	127K	321K	866K	1.06M	48.2K	15.98K	7.72K	922.00	1.48K	1.66K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-26.29M	-37.43M	-35.84M	-47.51M	-45.36M	-27.47M	-10.77M	-9.45M	-7.21M	-26.2M	-5.74M	-14.55M	-4.56M	-8.1M	-8.22M	-23.86M	-12.62M	-12.62M	-16.31M	-12.62M	-19.49M	-39.02M	90.66M	52.88M	-36.8M	17.9M	-6.5M	8.4M	-7.71M	-5.12M	-6.24M	-1.4M	-20K
Net Income	-26.94M	-39.41M	-37.77M	-62.57M	-51.41M	-27.47M	-10.77M	-9.45M	-7.21M	-26.2M	-5.74M	-14.55M	-4.56M	-8.1M	-8.22M	-23.86M	-22.41M	-49.89M	-16.31M	-12.62M	-19.49M	-39.02M	-43.31M	-48.79M	-36.9M	-13.5M	-6.5M	-4.8M	-7.71M	-5.12M	-6.24M	-1.4M	-20K
Selling & General & Admin	41.84M	37.77M	38.47M	27.48M	30.44M	18M	3.16M	4.78M	3.12M	3.76M	2.99M	2.8M	3.05M	3.4M	4.1M	7.76M	7.39M	7.39M	5.92M	6.57M	7.02M	13.93M	15.82M	12.67M	8M	5.8M	4.9M	3.4M	2.46M	1.55M	1.55M	810K	20K
Research & Development	9.86M	16M	14.42M	11.47M	9.75M	8.51M	7.6M	4.65M	4.08M	2.77M	2.75M	2.38M	3.46M	4.83M	7.9M	20.07M	23.74M	21.67M	17.33M	10.52M	14.25M	31.31M	52.86M	41.72M	35.5M	15.1M	9M	n/a	5.94M	3.67M	4.77M	650K	n/a
Other Expenses	-6.57M	44K	558K	82K	5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.08M	900K	700K	300K	200K	n/a	n/a	10K	n/a	n/a
Operating Expenses	45.13M	53.77M	52.89M	38.95M	40.19M	26.5M	10.75M	9.42M	7.19M	6.52M	5.74M	5.17M	6.51M	8.23M	12.01M	27.83M	31.13M	29.06M	23.25M	17.09M	21.28M	45.24M	68.67M	55.47M	44.4M	21.6M	14.2M	3.6M	8.4M	5.22M	6.33M	1.46M	20K
Interest Expense	n/a	28.98M	n/a	n/a	n/a	8.21K	14.98K	33.81K	82.45K	28.06K	n/a	10.04M	n/a	540.22K	1.49M	2.22M	793.39K	156.79K	n/a	n/a	n/a	390.94K	344.97K	241.45K	n/a	n/a	n/a	n/a	-20K	20K	90K	60K	n/a
Selling & Marketing Expenses	16.45M	14.33M	14.71M	7.82M	3.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	58.96M	69.6M	65.45M	48.45M	44.12M	26.5M	10.75M	9.42M	7.2M	6.53M	5.74M	5.17M	6.51M	8.23M	12.01M	27.83M	31.13M	29.06M	23.25M	17.09M	21.28M	45.24M	68.67M	54.39M	43.5M	20.9M	13.9M	11M	8.4M	5.22M	6.33M	1.46M	20K
Income Tax Expense	-81K	1.98M	1.93M	15.06M	6.05M	-958.91K	14.98K	33.81K	82.45K	28.06K	-11.48M	-9.01M	-9.5K	3.57M	1.49M	3.51M	-540.04K	28.19M	-1.01M	-3.96M	-205.58K	-5.04M	-23.5M	-1.92M	-1.6M	-2.2M	-2.6M	-1.8M	-40K	30K	180K	n/a	n/a
Shares Outstanding (Basic)	13.36M	13.65M	13.61M	11.05M	9.59M	8.48M	6.15M	5.59M	3.24M	2.86M	2.61M	1.91M	1.18M	967.89K	797.8K	786.18K	765.15K	653.4K	437.97K	337.91K	272.21K	199.02K	164.48K	145.97K	125.47K	115.29K	109.43K	89.05K	500K	430K	840K	840K	840K
Shares Outstanding (Diluted)	13.36M	13.65M	13.61M	11.05M	9.59M	8.48M	6.15M	5.59M	3.24M	2.86M	2.61M	1.91M	1.18M	967.89K	797.8K	786.18K	765.15K	653.4K	437.97K	337.91K	272.21K	199.02K	164.48K	145.97K	125.47K	115.29K	109.43K	89.05K	500K	430K	840K	840K	840K
EPS (Basic)	-2.02	-2.89	-2.78	-5.66	-5.36	-3.24	-1.75	-1.69	-2.22	-9.16	-2.2	-7.63	-3.87	-8.37	-10.3	-30.35	-29.29	-76.35	-37.25	-37.35	-71.61	-196.07	-263.3	-334.27	-294.11	-117.1	-59.4	-53.9	-15.42	-11.91	-7.43	-1.67	-0.02
EPS (Diluted)	-2.02	-2.89	-2.78	-5.66	-5.36	-3.24	-1.75	-1.69	-2.22	-9.16	-2.2	-7.63	-3.87	-8.37	-10.3	-30.35	-29.29	-76.35	-37.25	-37.35	-71.61	-196.07	-263.3	-334.27	-294.11	-117.1	-59.4	-53.9	-15.42	-11.91	-7.43	-1.67	-0.02
EBITDA	-21.54M	-24.07M	-32.75M	-31.35M	-37.43M	-25.79M	-10.64M	-9.35M	-7.06M	-26.13M	-5.72M	-4.48M	-4.52M	-4.46M	-6.63M	-21.33M	-21.28M	-22.64M	-15.84M	-11.85M	-18.77M	-42.56M	-65.44M	-49.64M	-37.58M	-15M	-8.8M	-6.2M	-7.53M	-4.95M	-6.07M	-1.34M	-20K
EBIT	-25.28M	-26.49M	-35.22M	-33.31M	-39.58M	-27.46M	-10.76M	-9.42M	-7.12M	-26.17M	-5.74M	-4.5M	-4.56M	-4.53M	-6.72M	-20.36M	-23.73M	-22.17M	-17.33M	-16.58M	-19.7M	-44.06M	-66.81M	-50.72M	-38.48M	-15.7M	-9.1M	-6.4M	-7.73M	-5.1M	-6.15M	-1.34M	n/a
Depreciation & Amortization	3.74M	2.42M	3.1M	3.23M	2.15M	1.67M	117.78K	66.45K	68.38K	48.18K	17.39K	20.46K	38.12K	70.36K	95.11K	319.23K	-779.15K	-469.13K	155.02K	773.77K	930.77K	1.51M	1.38M	1.08M	900K	700K	300K	200K	200K	150K	80K	120K	n/a